首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   254203篇
  免费   18094篇
  国内免费   1130篇
耳鼻咽喉   2807篇
儿科学   6577篇
妇产科学   4629篇
基础医学   33220篇
口腔科学   4615篇
临床医学   25693篇
内科学   54053篇
皮肤病学   3418篇
神经病学   24415篇
特种医学   8449篇
外国民族医学   11篇
外科学   38713篇
综合类   3491篇
一般理论   319篇
预防医学   21674篇
眼科学   6598篇
药学   17166篇
  6篇
中国医学   363篇
肿瘤学   17210篇
  2023年   1345篇
  2022年   2418篇
  2021年   5455篇
  2020年   3278篇
  2019年   5335篇
  2018年   5988篇
  2017年   4495篇
  2016年   4989篇
  2015年   5869篇
  2014年   8657篇
  2013年   11868篇
  2012年   18111篇
  2011年   19001篇
  2010年   10623篇
  2009年   9488篇
  2008年   16691篇
  2007年   17544篇
  2006年   17414篇
  2005年   17389篇
  2004年   16263篇
  2003年   15142篇
  2002年   14142篇
  2001年   2189篇
  2000年   1670篇
  1999年   2382篇
  1998年   3099篇
  1997年   2588篇
  1996年   2215篇
  1995年   2123篇
  1994年   1764篇
  1993年   1588篇
  1992年   1308篇
  1991年   1199篇
  1990年   1037篇
  1989年   1013篇
  1988年   1012篇
  1987年   985篇
  1986年   996篇
  1985年   1004篇
  1984年   1246篇
  1983年   1148篇
  1982年   1383篇
  1981年   1325篇
  1980年   1156篇
  1979年   729篇
  1978年   764篇
  1977年   655篇
  1976年   606篇
  1975年   495篇
  1974年   488篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
Microvascular thrombosis is a prominent feature in cardiac delayed xenograft rejection (DXR). We investigated the impact of warfarin or low-molecular-weight heparin (LMWH) anti-coagulation on xenograft function using a heterotopic pig-to-primate model. Donor hearts were from CD46 transgenic pigs and baboon immunosuppression included tacrolimus, sirolimus, anti-CD20 and TPC, an alpha-galactosyl-polyethylene glycol conjugate. Three groups of animals were studied. Group 1 (n = 9) was treated with warfarin, Group 2 (n = 13) with LMWH and Group 3, received no anti-coagulant drugs. The median duration of xenograft function was 20 days (range 3-62 days), 18 days (range 5-109 days) and 15 days (range 4-53 days) in Groups 1 to 3 respectively. Anti-coagulation achieved the targeted international normalized prothrombin ratio (INR) and anti-factor Xa levels consistent with effective in vivo therapy yet, no significant impact on median xenograft function was observed. At rejection, a similar histology of thrombosis and ischemia was apparent in each group and the levels of fibrin deposition and platelet thrombi in rejected tissue was the same. Anti-coagulation with warfarin or LMWH did not have a significant impact on the onset of DXR and microvascular thrombosis. However, a role for specific anti-coagulant strategies to achieve long-term xenograft function cannot be excluded.  相似文献   
73.
The purpose of this study was to provide, in a large number of patients, comprehensive Doppler echocardiographic assessment of normal St Jude Medical mitral valve prosthesis function using Doppler-derived hemodynamic variables, including the mitral valve prosthesis-to-left ventricular outflow tract time-velocity integral ratio and prosthesis performance index. The pressure half-time was less than 130 milliseconds in all patients, and all but one patient had either a peak early mitral diastolic velocity of 2 m/s or less or a mitral valve prosthesis-to-left ventricular outflow tract time-velocity integral ratio of less than 2.2. There was a significant (P < .001) negative correlation between the prosthesis performance index and prosthesis size. This negative correlation suggests that there is more efficient use of the in vitro geometric orifice area with smaller prostheses.  相似文献   
74.
OBJECTIVE: This study was designed to investigate potential areas of practice for the clinical laboratory scientist (CLS) and to propose a graduate curriculum to prepare the practitioner for an advanced level of practice. DESIGN: Meta-analysis of PharmD, physician assistant, physical therapy, and nurse practitioner curricula focusing on academic and clinical advanced practice was used to develop an educational model and curriculum for a professional doctorate in clinical laboratory science (CLS). MAIN OUTCOME MEASURE: (1) New educational model for CLS advanced practice; (2) A proposed curriculum for a Doctorate of Clinical Laboratory Science degree. RESULTS: A new curriculum model was adapted from established healthcare educational models. CONCLUSION: Although there is a need for a baccalaureate degree in CLS there is also a role for expanded education and responsibilities for CLS practitioners. The CLS Advanced Practitioner design focuses on moving students from the baccalaureate level to the doctoral level and prepares the individual to become an integral part of the healthcare team.  相似文献   
75.
76.
77.
Dental management of patients with autoimmune vesiculobullous disorders is complicated because of prominent involvement of oral mucosa, increased risk of oral disease, and difficulty in rendering dental care. Although these diseases are relatively uncommon, dental practitioners should be familiar with the oral sequelae of these conditions and their management. Pemphigus vulgaris, cicatricial pemphigoid, and epidermolysis bullosa represent the most common autoimmune oral vesiculobullous diseases. This case-illustrated review summarizes the pathogenesis, diagnostic features, and natural history of oral vesiculobullous disorders, placing an emphasis on the treatment and prevention of associated oral disease aimed at maintaining a healthy, functional dentition.  相似文献   
78.
79.
80.
Originally described by Rosen in 1983, syringomatous nipple adenoma (SAN) is a tumor of disputed histogenesis, which can be problematic both diagnostically and therapeutically. 1 It is a benign primary tumor of breast epithelium with histology similar to that of the syringoma. In the current case, we describe a 40-year-old female with this lesion occurring within a supernumerary breast. This case represents, to our knowledge, the first such reported case, and represents a significant finding as its presence could lend some confusion as to whether or not this represents a benign primary process of breast or a potentially infiltrative tumor of the skin.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号